Patents by Inventor Denis Twomey

Denis Twomey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230042465
    Abstract: The present invention relates to methods of manufacture for producing anti-TNF antibodies, e.g., the anti-TNF antibody golimumab, and specific pharmaceutical compositions of the antibody.
    Type: Application
    Filed: July 8, 2022
    Publication date: February 9, 2023
    Inventors: Ann Donlon, Charles Goochee, Gary Gordon, Ronan Hayes, Robin Johnston, JR., Willem Steenvoorden, Denis Twomey
  • Publication number: 20230040065
    Abstract: The present invention relates to methods of manufacture for producing a drug substance (DS) or drug product (DP) comprising a mammalian anti-TNF antibody having a heavy chain (HC) comprising SEQ ID NO: 36 and a light chain (LC) comprising SEQ ID NO: 37.
    Type: Application
    Filed: July 8, 2022
    Publication date: February 9, 2023
    Inventors: Kristopher Barnthouse, John Brown, Brett Hanna, Linda Hendricks, Manuel Lopez, JR., Mark Panek, Denis Twomey, David Volkin
  • Publication number: 20230038355
    Abstract: The present disclosure relates to methods of manufacture for producing anti-IL-12/IL-23p40 antibodies, e.g., the anti-IL-12/IL-23p40 antibody ustekinumab, and specific pharmaceutical compositions of the antibody.
    Type: Application
    Filed: July 8, 2022
    Publication date: February 9, 2023
    Inventors: Ann Donlon, Charles Goochee, Ronan Hayes, Robin Johnston, Willem Steenvoorden, Denis Twomey, Gary Gordon